BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 11716193)

  • 1. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
    Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
    Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.
    Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G
    Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bone mineral density is common after autologous blood or marrow transplantation.
    Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
    Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation.
    Kananen K; Volin L; Tähtelä R; Laitinen K; Ruutu T; Välimäki MJ
    Bone Marrow Transplant; 2002 Jan; 29(1):33-9. PubMed ID: 11840142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
    Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
    Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age, body mass index, current smoking history, and serum insulin-like growth factor-I levels associated with bone mineral density in middle-aged Korean men.
    Rhee EJ; Oh KW; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Park CY; Choi MG; Yoo HJ; Park SW
    J Bone Miner Metab; 2004; 22(4):392-8. PubMed ID: 15221500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.
    Krieg MA; Seydoux C; Sandini L; Goy JJ; Berguer DG; Thiébaud D; Burckhardt P
    Osteoporos Int; 2001; 12(2):112-6. PubMed ID: 11303710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
    Kananen K; Volin L; Laitinen K; Alfthan H; Ruutu T; Välimäki MJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3877-85. PubMed ID: 15797959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate prevents further bone loss in renal transplant recipients.
    Giannini S; D'Angelo A; Carraro G; Nobile M; Rigotti P; Bonfante L; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
    J Bone Miner Res; 2001 Nov; 16(11):2111-7. PubMed ID: 11697808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
    Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
    Yang LJ; Shen FX; Zheng JC; Zhang HL
    Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms?
    Ferrari SL; Rizzoli R; Slosman DO; Bonjour JP
    J Bone Miner Res; 1998 Mar; 13(3):363-70. PubMed ID: 9525336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    Triantafyllou N; Lambrinoudaki I; Thoda P; Andreadou E; Kararizou E; Alexandrou A; Limouris G; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2012 Feb; 313(1-2):137-41. PubMed ID: 21992813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.